CH658389A5 - Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose. - Google Patents

Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose. Download PDF

Info

Publication number
CH658389A5
CH658389A5 CH925/84A CH92584A CH658389A5 CH 658389 A5 CH658389 A5 CH 658389A5 CH 925/84 A CH925/84 A CH 925/84A CH 92584 A CH92584 A CH 92584A CH 658389 A5 CH658389 A5 CH 658389A5
Authority
CH
Switzerland
Prior art keywords
prophylaxis
diltiazem
treatment
arteriosclerosis
composition according
Prior art date
Application number
CH925/84A
Other languages
German (de)
English (en)
Inventor
Azusa Okaniwa
Hitoshi Iwasaki
Kazuyuki Kitamura
Takashi Morita
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of CH658389A5 publication Critical patent/CH658389A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CH925/84A 1983-02-25 1984-02-24 Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose. CH658389A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58031515A JPS59157021A (ja) 1983-02-25 1983-02-25 動脈硬化症予防治療剤

Publications (1)

Publication Number Publication Date
CH658389A5 true CH658389A5 (de) 1986-11-14

Family

ID=12333337

Family Applications (1)

Application Number Title Priority Date Filing Date
CH925/84A CH658389A5 (de) 1983-02-25 1984-02-24 Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose.

Country Status (12)

Country Link
JP (1) JPS59157021A (fr)
BE (1) BE899000A (fr)
CH (1) CH658389A5 (fr)
DE (1) DE3406837A1 (fr)
DK (1) DK163712C (fr)
FR (1) FR2541577B1 (fr)
GB (1) GB2135192B (fr)
HK (1) HK45389A (fr)
IT (1) IT1178863B (fr)
NL (1) NL8400548A (fr)
SE (1) SE8400971L (fr)
SG (1) SG21189G (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
US4786634A (en) * 1986-05-23 1988-11-22 Tanabe Seikyaku Co., Ltd. Method for treating arteriosclerosis
JP2658783B2 (ja) * 1992-12-10 1997-09-30 田辺製薬株式会社 抗動脈硬化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1236467A (en) * 1967-10-28 1971-06-23 Tanabe Seiyaku Co Benzothiazepine derivatives
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives

Also Published As

Publication number Publication date
IT8467183A1 (it) 1985-08-24
DK103084A (da) 1984-08-26
IT8467183A0 (it) 1984-02-24
GB2135192B (en) 1986-10-22
JPS6358809B2 (fr) 1988-11-17
HK45389A (en) 1989-06-16
IT1178863B (it) 1987-09-16
GB2135192A (en) 1984-08-30
NL8400548A (nl) 1984-09-17
FR2541577A1 (fr) 1984-08-31
SE8400971D0 (sv) 1984-02-22
FR2541577B1 (fr) 1987-05-22
DK163712C (da) 1992-08-31
SG21189G (en) 1990-01-26
DK103084D0 (da) 1984-02-24
GB8405060D0 (en) 1984-04-04
JPS59157021A (ja) 1984-09-06
BE899000A (fr) 1984-06-18
DE3406837C2 (fr) 1990-12-20
SE8400971L (sv) 1984-08-26
DK163712B (da) 1992-03-30
DE3406837A1 (de) 1984-08-30

Similar Documents

Publication Publication Date Title
CH644267A5 (en) Pharmaceutical compositions containing (all-Z)-5,8,11,14,17-eicosapentaenoic acid or one of its pharmaceutically acceptable salts, esters or amides
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
AT389998B (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE3639378C2 (fr)
DE3390114T1 (de) Verbesserte analgetische und antiinflammatorische, Ibuprofen enthaltende Zubereitungen und Verfahren zu ihrer Herstellung
EP0214620A2 (fr) Forme d'application transdermique de diltiazem
DE69006707T2 (de) Verwendung von Fluorochinolon-Derivaten zur Behandlung der Pneumocystis carinii Pneumonie.
CH646056A5 (de) Lipide senkendes mittel.
DE2514335C3 (de) Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung
EP0224810B1 (fr) Préparation antihypertensive contenant un mélange
DE3643119A1 (de) Therapeutische zusammensetzung fuer diabetes-komplikationen
DE60206280T2 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
CH660556A5 (de) Therapeutische zubereitung zur behandlung von kardiovaskulaeren krankheiten.
DE69308762T2 (de) Behandlung des Muskulschwunds
CH658389A5 (de) Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose.
DE2335216A1 (de) Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE69004529T2 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
EP0557876B1 (fr) Utilisation de dérivées de la xanthine pour le traitement des dommages musculaires après l'interruption complète de la circulation sanguine
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
EP0979083B1 (fr) Utilisation de 1-ar(alk)yl-imidazolin-2-one pour le traitement de l'angoisse et du stress
WO1998058639A1 (fr) Compositions a effet synergique pour lutter selectivement contre les tissus tumoraux
DE3781456T2 (de) Pharmazeutische zusammensetzung, die eine 8-chlor-benzothiazepin-verbindung enthaelt und ihre verwendung.
DE60109799T2 (de) Verwendung von quetiapin für aufmerksamkeitsmangel-hyperaktivitätsstörungen oder verhaltensstörungen
DE3410850A1 (de) Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung

Legal Events

Date Code Title Description
PL Patent ceased